KLRA

Conviction 100HealthcareScan · Fri, Jun 26, 2026

KLRA$20.76+0.48%

ResistanceSupportVol 14Insider buy

Vol MA14 1.17M

Apr 17May 1May 14May 29Jun 11Jun 26

Kailera Therapeutics, Inc.Biotechnologywww.kailera.com ↗

Price20.76

Change+0.48%

Gap-1.50%

Rel volume8.04×

Avg volume954.17K

Avg $ vol19.55M

SMA 2020.63

SMA 50—

SMA 200—

Price vs 50—

Price vs 200—

MA stack—

50/200 cross—

Supertrenddown · 24.04

RSI (14)48

MACD hist0.26

MACD crossbull · 4d

Stoch %K / %D51 / 55

ADX (14)20

+DI / −DI15 / 19

RSI divergenceBullish

MACD divergence—

ATR %+7.89%

ADR %7.56%

52w high26.00

52w low18.55

From 52w high-20.15%

Above 52w low+11.91%

New 52w highNo

SqueezeOff

Bollinger width28.41%

%B0.52

Donchian pos39.72%

Donchian high24.19

Donchian low18.50

AVWAP (52w high)22.03

vs AVWAP high-5.78%

AVWAP (52w low)20.32

vs AVWAP low+2.15%

OBV trendUp

Chaikin MF (20)0.04

Today vs 20d8.04×

Avg vol (14d)1.17M

Avg vol (20d)954.17K

Avg $ vol (20d)19.55M

Market cap—

RS 3m (vs SPY)—

RS 6m (vs SPY)—

RS line new highNo

Trend template—

Technical rank24.3

1 week+4.32%

1 month-5.25%

3 months—

6 months—

1 year—

YTD-20.15%

P/E—

P/B-6.20

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current9.67

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target39.00

Target upside88.68%

Analyst ratingBuy

Institutional—

Ent. value2.57B

Revenue—

Net income-78.86M

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out129.57M

Employees—

ListedFri, Apr 17, 2026

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA+

Conviction100 / 100

Pattern quality—

Tech rank24.3 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance24.95

Support18.68

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in KLRA

All disclosures →

No recent disclosed trades by Congress in KLRA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in KLRA · 5 buys · 4 sells

Insider	Side	Shares	Value	Traded	Filed
Jiangsu Hengrui Pharmaceuticals Co., Ltd. 10% owner · Common Stock · 2026-04-20	Convert	9.48M	—	2026-04-20	2026-04-22
WONG RODERICK 10% owner · Common Stock · 2026-04-20	Convert	10.28M	—	2026-04-20	2026-04-22
WONG RODERICK 10% owner · Common Stock · 2026-04-20	Buy	500K	$8.0M	2026-04-20	2026-04-22
RTW INVESTMENTS, LP 10% owner · Series B Preferred Stock · 2026-04-20	Convert	2.03M	—	2026-04-20	2026-04-22
RTW INVESTMENTS, LP 10% owner · Series A Preferred Stock · 2026-04-20	Convert	8.25M	—	2026-04-20	2026-04-22
WONG RODERICK 10% owner · Series B Preferred Stock · 2026-04-20	Convert	2.03M	—	2026-04-20	2026-04-22
RTW INVESTMENTS, LP 10% owner · Common Stock · 2026-04-20	Buy	500K	$8.0M	2026-04-20	2026-04-22
Jiangsu Hengrui Pharmaceuticals Co., Ltd. 10% owner · Common Stock · 2026-04-20	Other	—	—	2026-04-20	2026-04-22
RTW INVESTMENTS, LP 10% owner · Common Stock · 2026-04-20	Convert	10.28M	—	2026-04-20	2026-04-22
WONG RODERICK 10% owner · Series A Preferred Stock · 2026-04-20	Convert	8.25M	—	2026-04-20	2026-04-22

SEC filings

EDGAR filings in KLRA

EDGAR →

No recent SEC filings on file for KLRA.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.